The dependence of electronic absorption spectra antimicrobial property on the substituent position was investigated using three Schiff bases derived from salicylaldehyde and isomeric aminobenzoic acids in three solven...The dependence of electronic absorption spectra antimicrobial property on the substituent position was investigated using three Schiff bases derived from salicylaldehyde and isomeric aminobenzoic acids in three solvents of different polarities. The absorption maxima in all three solvents exhibited dependence on the position of substituent with the absorption maxima undergoing a red shift as solvent polarity increased. The in vitro antibacterial activity of the compounds against some clinically important bacteria namely Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 25923), Enterococcus feacalis (ATCC 29212) was determined in N,N”-dimethylformamide and 1,4-dioxane using the agar dilution method. The results revealed that the ortho and meta substituted Schiff bases exhibited better antimicrobial activity in the non-polar solvent.展开更多
<span style="font-family:Verdana;">Three Schiff bases L</span><sub><span style="font-family:Verdana;">1</span></sub><span style="font-family:Verdana;&quo...<span style="font-family:Verdana;">Three Schiff bases L</span><sub><span style="font-family:Verdana;">1</span></sub><span style="font-family:Verdana;">, L</span><sub><span style="font-family:Verdana;">2</span></sub><span style="font-family:Verdana;"> and L</span><sub><span style="font-family:Verdana;">3</span></sub><span style="font-family:Verdana;"> were synthesized by condensing salicylalde</span><span style="font-family:Verdana;">hyde with 4-aminoantipyrine, ethylendiamine and 2-aminophenol respec</span><span style="font-family:Verdana;">tively and subsequently characterized by various physicochemical investigations. All the three compounds were screened for their </span><i><span style="font-family:Verdana;">In-vitro</span></i><span style="font-family:Verdana;"> antibacterial activity against two gram positive bacteria, </span><i><span style="font-family:Verdana;">Staphylococcus aureus</span></i><span style="font-family:Verdana;"> (S.A), </span><i><span style="font-family:Verdana;">Staphylococcus epidermidis</span></i><span style="font-family:Verdana;"> (S.E) and two gram negative bacteria </span><i><span style="font-family:Verdana;">Klebsiella</span></i><span><span><i><span style="font-family:""> </span></i></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><i><span style="font-family:Verdana;">pneumoniae</span></i></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> (K.P) and </span><i><span style="font-family:Verdana;">Pseudomonas aeruginosa </span></i><span style="font-family:Verdana;">(</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">P.</span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">A) by agar diffusion method. On comparing the results obtained with the activity of commercially available antibiotics such as Ciprofloxacin and Chloramphenicol, the newly synthesized compounds showed comparable antibacterial activities. The solvent methanol exhibit activity against all bacterial species with IZs ranging from 8 ± 0.25 to 17 ± 0.29 mm while the standard antibiotics Ciprofloxacin and Chloramphenicol exhibited an activities with IZs varying from 21.3 ± 0.31 to 28.3 ± 0.32 and 26.3 ± 0.24 mm to 32.3 ± 0.23 mm, respectively. However, the newly synthesized Schiff bases L</span><sub><span style="font-family:Verdana;">1</span></sub><span style="font-family:Verdana;">, L</span><sub><span style="font-family:Verdana;">2</span></sub><span style="font-family:Verdana;"> and L</span><sub><span style="font-family:Verdana;">3</span></sub><span style="font-family:Verdana;"> showed IZs ranging from 7.4 ± 0.23 to 32.5 ± 0.14, 3 ± 0.57 to 12 ± 0.28 and 10 ± 0.20 to 32 ± 0.36 respectively. Among the Schiff bases, L</span><sub><span style="font-family:Verdana;">3</span></sub><span style="font-family:Verdana;"> showed the activity (32 ± 0.36) against S.E and P.A </span><span style="font-family:Verdana;">which is higher than the activity of standard antibiotics Ciprofloxacin and</span><span style="font-family:Verdana;"> Chloramphenicol against the same bacterial strains. The results obtained revealed that all the synthesized Schiff bases exhibit appreciable antibacterial activity against all the bacteria species which potentially makes them, to apply as wide range antibacterial drugs, after further </span><i><span style="font-family:Verdana;">in-vivo</span></i><span style="font-family:Verdana;"> cytotoxicity investigations. Their activity can also be further modified by changing the functionality of precursors for Schiff base condensation.</span></span></span></span>展开更多
文摘The dependence of electronic absorption spectra antimicrobial property on the substituent position was investigated using three Schiff bases derived from salicylaldehyde and isomeric aminobenzoic acids in three solvents of different polarities. The absorption maxima in all three solvents exhibited dependence on the position of substituent with the absorption maxima undergoing a red shift as solvent polarity increased. The in vitro antibacterial activity of the compounds against some clinically important bacteria namely Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 25923), Enterococcus feacalis (ATCC 29212) was determined in N,N”-dimethylformamide and 1,4-dioxane using the agar dilution method. The results revealed that the ortho and meta substituted Schiff bases exhibited better antimicrobial activity in the non-polar solvent.
文摘<span style="font-family:Verdana;">Three Schiff bases L</span><sub><span style="font-family:Verdana;">1</span></sub><span style="font-family:Verdana;">, L</span><sub><span style="font-family:Verdana;">2</span></sub><span style="font-family:Verdana;"> and L</span><sub><span style="font-family:Verdana;">3</span></sub><span style="font-family:Verdana;"> were synthesized by condensing salicylalde</span><span style="font-family:Verdana;">hyde with 4-aminoantipyrine, ethylendiamine and 2-aminophenol respec</span><span style="font-family:Verdana;">tively and subsequently characterized by various physicochemical investigations. All the three compounds were screened for their </span><i><span style="font-family:Verdana;">In-vitro</span></i><span style="font-family:Verdana;"> antibacterial activity against two gram positive bacteria, </span><i><span style="font-family:Verdana;">Staphylococcus aureus</span></i><span style="font-family:Verdana;"> (S.A), </span><i><span style="font-family:Verdana;">Staphylococcus epidermidis</span></i><span style="font-family:Verdana;"> (S.E) and two gram negative bacteria </span><i><span style="font-family:Verdana;">Klebsiella</span></i><span><span><i><span style="font-family:""> </span></i></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><i><span style="font-family:Verdana;">pneumoniae</span></i></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;"> (K.P) and </span><i><span style="font-family:Verdana;">Pseudomonas aeruginosa </span></i><span style="font-family:Verdana;">(</span></span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">P.</span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">A) by agar diffusion method. On comparing the results obtained with the activity of commercially available antibiotics such as Ciprofloxacin and Chloramphenicol, the newly synthesized compounds showed comparable antibacterial activities. The solvent methanol exhibit activity against all bacterial species with IZs ranging from 8 ± 0.25 to 17 ± 0.29 mm while the standard antibiotics Ciprofloxacin and Chloramphenicol exhibited an activities with IZs varying from 21.3 ± 0.31 to 28.3 ± 0.32 and 26.3 ± 0.24 mm to 32.3 ± 0.23 mm, respectively. However, the newly synthesized Schiff bases L</span><sub><span style="font-family:Verdana;">1</span></sub><span style="font-family:Verdana;">, L</span><sub><span style="font-family:Verdana;">2</span></sub><span style="font-family:Verdana;"> and L</span><sub><span style="font-family:Verdana;">3</span></sub><span style="font-family:Verdana;"> showed IZs ranging from 7.4 ± 0.23 to 32.5 ± 0.14, 3 ± 0.57 to 12 ± 0.28 and 10 ± 0.20 to 32 ± 0.36 respectively. Among the Schiff bases, L</span><sub><span style="font-family:Verdana;">3</span></sub><span style="font-family:Verdana;"> showed the activity (32 ± 0.36) against S.E and P.A </span><span style="font-family:Verdana;">which is higher than the activity of standard antibiotics Ciprofloxacin and</span><span style="font-family:Verdana;"> Chloramphenicol against the same bacterial strains. The results obtained revealed that all the synthesized Schiff bases exhibit appreciable antibacterial activity against all the bacteria species which potentially makes them, to apply as wide range antibacterial drugs, after further </span><i><span style="font-family:Verdana;">in-vivo</span></i><span style="font-family:Verdana;"> cytotoxicity investigations. Their activity can also be further modified by changing the functionality of precursors for Schiff base condensation.</span></span></span></span>